Table 5 Association between separate endpoints survival and groups which divided by TyG in patients with plaque erosion

MACE

 1

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

 2

0.20 (0.02,1.74)

0.146

0.12 (0.01,1.70)

0.118

0.69 (0.0,741.76)

0.916

0.09 (0.00,4.23)

0.218

 3

0.19 (0.02,1.62)

0.128

0.13 (0.01,1.18)

0.070

0.07 (0.00,1.79)

0.106

0.02 (0.00,0.91)

0.045*

 Trend test

0.37 (0.12,1.13)

0.080

0.30 (0.09,1.01)

0.051

0.26 (0.05,1.28)

0.097

0.14 (0.02,0.92)

0.041*

Revascularization

 1

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

 2

0.76 (0.17,3.40)

0.718

0.75 (0.17,3.37)

0.705

0.77 (0.13,4.67)

0.777

0.73 (0.11,4.71)

0.737

 3

1.21 (0.32,4.51)

0.778

1.24 (0.32,4.71)

0.756

0.98 (0.23,4.11)

0.979

0.93 (0.21,4.12)

0.922

 Trend test

1.11 (0.56,2.23)

0.761

1.13 (0.56,2.28)

0.742

0.99 (0.48,2.05)

0.975

0.97 (0.45,2.07)

0.933

Angina

 1

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

 2

0.51 (0.09,2.76)

0.431

0.41 (0.08,2.27)

0.309

0.37 (0.04,3.08)

0.357

0.29 (0.03,3.06)

0.304

 3

0.49 (0.09,2.67)

0.408

0.38 (0.07,2.13)

0.274

0.19 (0.02,1.73)

0.140

0.19 (0.01,2.42)

0.201

 Trend test

0.68 (0.28,1.62)

0.380

0.59 (0.24,1.45)

0.250

0.42 (0.14,1.27)

0.125

0.41 (0.12,1.43)

0.163

Bleeding events

 1

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

1 (reference)

 2

1.45 (0.72,2.92)

0.295

1.43 (0.71,2.89)

0.313

1.42 (0.63,3.23)

0.397

1.46 (0.63,3.39)

0.379

 3

1.80 (0.93,3.50)

0.083

1.75 (0.89,3.41)

0.102

2.16 (1.00,4.67)

0.049*

2.50 (1.11,5.65)

0.028*

 Trend test

1.33 (0.96,1.85)

0.083

1.31 (0.95,1.82)

0.103

1.47 (1.00,2.16)

0.047*

1.59 (1.06,2.39)

0.027*